Kate Sumpter

Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study

Richard Fox, Daniel H. Palmer, Hassan Malik et al. · The Lancet Oncology · 2019 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +9

Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team

Jessica Dyson, Bryan Jaques, D. Chattopadyhay et al. · Journal of Hepatology · 2013 · 597 citations · Full text

Medicine, Endocrinology, Oncology +16

Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons From the ESPAC-3 Study

Juan W. Valle, Daniel H. Palmer, Richard Jackson et al. · Journal of Clinical Oncology · 2014 · 455 citations · Full text

Medicine, Oncology, Surgery +16

Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial

David Cunningham, Sally Stenning, Elizabeth Smyth et al. · The Lancet Oncology · 2017 · 288 citations · Full text

Medicine, Oncology, Surgery +14

Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF

Kate Sumpter, Catherine Harper‐Wynne, David Cunningham et al. · British Journal of Cancer · 2005 · 145 citations · Full text

Medicine, Oncology, Pharmacology +17